InsiderClue
Insiders · Profile

Schultes Birgit C

EVP, Chief Scientific Officer at Intellia Therapeutics. Filing since 1 Oct 2025. CIK 0002051419

Company
Date
Role
Action
Shares
Amount
Of holding
NTLA Intellia Therapeutics, Inc.
5 Jan 2026
EVP, Chief Scientific Officer
Sold at will
8,508
$78.36K
7.9%
NTLA Intellia Therapeutics, Inc.
1 Oct 2025
EVP, Chief Scientific Officer
Sold at will
31
$538.78
0.0%
2 decisions on file.